EUR 2.0
(1.01%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -8.63 Million EUR | 22.58% |
2022 | -11.15 Million EUR | -3.25% |
2021 | -10.8 Million EUR | -9.77% |
2020 | -9.84 Million EUR | -37.22% |
2019 | -7.17 Million EUR | 33.03% |
2018 | -10.71 Million EUR | -40.74% |
2017 | -7.61 Million EUR | -14.23% |
2016 | -6.66 Million EUR | -17.16% |
2015 | -5.68 Million EUR | -31.15% |
2014 | -4.33 Million EUR | -137.91% |
2013 | -1.82 Million EUR | -96.87% |
2012 | -925.75 Thousand EUR | -159.91% |
2011 | 1.54 Million EUR | 137.53% |
2010 | -4.11 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -6.4 Million EUR | 0.0% |
2023 Q2 | -4.56 Million EUR | 0.0% |
2023 FY | -8.63 Million EUR | 22.58% |
2023 Q4 | -4.07 Million EUR | 0.0% |
2022 FY | -11.15 Million EUR | -3.25% |
2022 Q2 | -5.87 Million EUR | 0.0% |
2022 Q4 | -5.28 Million EUR | 0.0% |
2021 Q4 | -5.35 Million EUR | 0.0% |
2021 FY | -10.8 Million EUR | -9.77% |
2021 Q2 | -5.44 Million EUR | 0.0% |
2020 Q2 | -5.25 Million EUR | 0.0% |
2020 Q4 | -4.58 Million EUR | 0.0% |
2020 FY | -9.84 Million EUR | -37.22% |
2019 Q4 | -2.22 Million EUR | 0.0% |
2019 FY | -7.17 Million EUR | 33.03% |
2019 Q2 | -4.95 Million EUR | 0.0% |
2018 Q2 | -3.25 Million EUR | 0.0% |
2018 FY | -10.71 Million EUR | -40.74% |
2018 Q4 | -7.45 Million EUR | 0.0% |
2017 FY | -7.61 Million EUR | -14.23% |
2017 Q4 | -4.25 Million EUR | 0.0% |
2017 Q2 | -3.36 Million EUR | 0.0% |
2016 Q4 | -3.83 Million EUR | 0.0% |
2016 Q2 | -2.83 Million EUR | 0.0% |
2016 FY | -6.66 Million EUR | -17.16% |
2015 Q4 | -2.12 Million EUR | 0.0% |
2015 Q2 | -3.55 Million EUR | 0.0% |
2015 FY | -5.68 Million EUR | -31.15% |
2014 Q2 | -2.08 Million EUR | 0.0% |
2014 FY | -4.33 Million EUR | -137.91% |
2014 Q4 | -2.24 Million EUR | 0.0% |
2013 Q1 | -455.64 Thousand EUR | 0.0% |
2013 FY | -1.82 Million EUR | -96.87% |
2013 Q4 | -1.27 Million EUR | -180.17% |
2013 Q3 | -455.64 Thousand EUR | 16.55% |
2013 Q2 | -546 Thousand EUR | -19.83% |
2012 FY | -925.75 Thousand EUR | -159.91% |
2012 Q1 | -288.6 Thousand EUR | 0.0% |
2012 Q2 | -288.6 Thousand EUR | 0.0% |
2012 Q3 | -288.6 Thousand EUR | 0.0% |
2012 Q4 | -455.64 Thousand EUR | -57.88% |
2011 Q4 | -288.6 Thousand EUR | 15.41% |
2011 FY | 1.54 Million EUR | 137.53% |
2011 Q3 | -341.18 Thousand EUR | 0.0% |
2011 Q2 | -341.18 Thousand EUR | 0.0% |
2011 Q1 | -341.18 Thousand EUR | 0.0% |
2010 Q1 | -912.76 Thousand EUR | 0.0% |
2010 Q4 | -341.18 Thousand EUR | 62.62% |
2010 Q3 | -912.76 Thousand EUR | 0.0% |
2010 FY | -4.11 Million EUR | 0.0% |
2010 Q2 | -912.76 Thousand EUR | 0.0% |
2009 Q4 | -912.76 Thousand EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Safe Orthopaedics SA | -6.96 Million EUR | -24.02% |
Spineway SA | -6.51 Million EUR | -32.688% |
Amplitude Surgical SA | 1.5 Million EUR | 675.867% |
Sartorius Stedim Biotech S.A. | 309.7 Million EUR | 102.789% |
EssilorLuxottica Société anonyme | 2.28 Billion EUR | 100.377% |
bonyf N.V. | -1.04 Million EUR | -726.836% |